Pyroptosis, a lytic form of programmed cell death, is typically initiated upon sensing pathogen-associated molecular patterns, with lipopolysaccharide (LPS) stimulation being a classic inducer. Prior studies established that Caspase-8 and RIPK1 can co-localize on lysosomes following LPS/5z-7 stimulation, suggesting lysosomes as pivotal signaling hubs. Intriguingly, this new investigation expands upon this observation by uncovering how the kinase RIOK2 influences the spatial reorganization of this killing complex within the cell, specifically facilitating its relocation to the ER.

The researchers employed confocal microscopy to visualize macrophages stimulated with LPS/5z-7, revealing a striking co-localization pattern between lysosomes and ER, indicating that these organelles physically interact during pyroptotic signaling. Notably, when RIOK2 was genetically deleted in immortalized bone marrow-derived macrophages (iBMDMs), this co-localization was substantially diminished, pointing to RIOK2 as a key regulator driving lysosomal transport to the ER.

To provide biochemical evidence supporting these cellular observations, the team isolated lysosomal and ER fractions from the stimulated macrophages. They discovered that while the FADD–RIPK1–Caspase-8 complex accumulated initially on lysosomes, it subsequently appeared in higher amounts on the ER over time. More importantly, RIOK2 deficiency had no significant impact on the complex’s presence in lysosomes but almost completely abolished its appearance on the ER, indicating that RIOK2’s role is specifically linked to facilitating translocation rather than initial complex formation.

The functional consequence of this translocation was underscored by examining Gasdermin D (GSDMD), a pore-forming protein whose cleavage is pivotal for executing pyroptosis. Increased cleavage of GSDMD at the ER followed LPS/5z-7 treatment in wild-type cells; however, in the absence of RIOK2, GSDMD cleavage was markedly reduced. This suggests that the lysosome-to-ER translocation orchestrated by RIOK2 is a prerequisite step enabling GSDMD activation and subsequent cell lysis.

Understanding the mechanism by which RIOK2 governs this intracellular transport led the researchers to explore the cytoskeletal machinery involved. Vesicle trafficking within cells typically relies on motor proteins traveling along cytoskeletal tracks. Among these, myosin II, a motor protein activated by phosphorylation at specific serine and threonine residues, emerged as a candidate collaborator with RIOK2.

Western blot analysis showed pronounced phosphorylation of myosin II in wild-type iBMDMs stimulated with LPS/5z-7, a modification absent in RIOK2-deficient cells. Pharmacological inhibition of myosin II using (-)-Blebbistatin prevented the coalescence of lysosomes and ER observed in stimulated cells, thereby corroborating myosin II’s essential role in lysosome translocation. Importantly, this inhibition had no further effect in RIOK2 knockout cells, suggesting that RIOK2 functions upstream of myosin II activation.

Further molecular interactions were uncovered through immunoprecipitation and mass spectrometry studies in TNFα + 5z-7 stimulated HeLa cells, identifying myosin II as a predominant FADD-interacting protein. These findings were reinforced by endogenous co-immunoprecipitation assays that confirmed a direct interaction between FADD, myosin II, and RIOK2. An in vitro kinase assay demonstrated that RIOK2, in the presence of FADD, mediates the phosphorylation of myosin II, implying that RIOK2 activates myosin II to facilitate lysosome movement toward the ER.

Functional assays demonstrated the biological impact of these molecular events. Treatment with the myosin II inhibitor significantly attenuated cell death, as measured by ATP levels, lactate dehydrogenase (LDH) release, and overall cell viability assays in LPS/5z-7 stimulated macrophages. Additionally, pro-inflammatory cytokine release, specifically IL-1β and IL-18, was reduced upon inhibition, reinforcing the centrality of the RIOK2-myosin II axis in pyroptosis induction.

This work elucidates a sophisticated regulatory layer in pyroptotic signaling, wherein RIOK2 acts as a kinase hub connecting death signal complexes to the transportation machinery, culminating in the activation of pyroptotic effectors. The spatial regulation of the FADD–RIPK1–Caspase-8 complex is shown to be a critical determinant for cell fate decisions in response to inflammatory stimuli.

Beyond basic cell biology, these findings carry immense translational potential. Pyroptosis plays a dual role—on one hand guarding against pathogens and, on the other hand contributing to pathological inflammation in diseases such as sepsis, autoimmune disorders, and cancer. Targeting RIOK2 or the downstream myosin II phosphorylation pathway offers a novel strategy to modulate pyroptotic responses therapeutically, potentially curbing excessive inflammation without compromising immune defense.

Moreover, unraveling the molecular choreography between lysosomes and ER adds to the growing appreciation of organelle crosstalk in immune signaling. The physical translocation of death-inducing complexes reflects an underexplored mechanism by which cells spatially organize and fine-tune inflammatory responses.

Future research may investigate whether similar regulatory mechanisms exist in other cell types and pathological contexts. Detailed structural studies of RIOK2 with its substrates could reveal further therapeutic targets. Additionally, exploring how other motor proteins and cytoskeletal elements contribute to pyroptosis will deepen our holistic understanding of cell death regulation.

In summary, the study powerfully demonstrates how RIOK2 kinase controls the dynamic intracellular trafficking of death complexes, linking lysosomal signaling hubs to the ER to facilitate Gasdermin D cleavage and pyroptosis. These insights pave the way for innovative treatments that modulate cell death pathways, offering hope for improved management of diverse inflammatory diseases.

Subject of Research: Regulation of pyroptosis through RIOK2-mediated translocation of the FADD–RIPK1–Caspase-8 complex and Gasdermin D cleavage.

Article Title: RIOK2 kinase regulates the translocation of the FADD–RIPK1–Caspase-8 complex to the ER and the cleavage of Gasdermin D to drive pyroptosis.

Article References:
Ma, M., Wang, F., Cui, P. et al. RIOK2 kinase regulates the translocation of the FADD–RIPK1–Caspase-8 complex to the ER and the cleavage of Gasdermin D to drive pyroptosis. Nat Commun 16, 10060 (2025). https://doi.org/10.1038/s41467-025-65012-7

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41467-025-65012-7

The crux of the discovery lies in the identification of LNPK as a pivotal marker for specialized ER junctions that localize close to lysosomes. These LNPK-positive ER sites act as hubs where secretome mRNAs—those encoding proteins destined for secretion or membrane localization—are preferentially translated. The significance of this finding cannot be overstated, as it adds a new dimension to our understanding of secretory pathway regulation, linking translation dynamics to subcellular organelle organization in an unprecedented manner.

Using innovative reporter constructs termed cytERM-SunTag–MS2, the research team visualized actively translating secretome mRNA puncta within living cells. These puncta consistently congregated adjacent to lysosomes identified by fluorescently tagged LAMP1, a canonical lysosomal membrane marker. This spatial association was not random; rather, it coincided with an increase in the SunTag fluorescent signal intensity, indicative of a higher ribosome density on mRNAs near lysosomes. In essence, the proximity to lysosomes appeared to potentiate translational activity, suggesting that lysosomes might serve as a platform or microenvironment favoring efficient protein synthesis.

Importantly, the researchers distinguished translating from non-translating mRNA species by tracking mobility dynamics. They observed that SiT-EGFP–MS2 reporters exhibiting confined motion—consistent with active ribosome engagement and polysome formation—were significantly closer to lysosomes than their highly mobile, presumably untranslated counterparts. This further substantiates the notion that translation of secretome mRNAs is spatially organized at ER–lysosome interfaces, where molecular crowding and localized signaling could optimize the recruitment of translation machinery.

Delving deeper into the molecular players involved, the study illuminated the indispensable role of LNPK in establishing and maintaining this specialized ER–lysosome interface. In experiments where LNPK expression was knocked down, the previously observed elevation in ribosome density near lysosomes vanished. This striking loss of spatially restricted enhanced translation highlights LNPK’s function as a critical architectural scaffold that shapes the ER network to form conducive microdomains for secretome mRNA translation.

The implications of these findings extend into fundamental cell biology and the broader understanding of intracellular logistics. Traditionally, the ER has been viewed as a broadly distributed membrane network responsible for protein folding and trafficking, while lysosomes have been primarily associated with degradation and recycling. The discovery that lysosomes also play a direct role in modulating the translation of secreted proteins revolutionizes this view, positioning lysosomes as active participants in protein biogenesis rather than mere endpoints in lysosomal degradation pathways.

Moreover, these insights provoke intriguing questions about how metabolic states and lysosomal activity might dynamically regulate secretome production. Given that lysosomes serve as nutrient sensors and hubs for cellular signaling, their ability to influence translation at adjacent ER sites could represent a sophisticated feedback mechanism. It is conceivable that cells adapt secretome output in response to environmental cues by modulating ER–lysosome junction architecture through LNPK-mediated remodeling.

Technically, the study leverages state-of-the-art imaging methodologies that combine translation reporters with organelle-specific fluorescent markers, enabling real-time visualization of molecular events at unprecedented resolution. This methodological innovation provides a powerful platform to dissect the spatiotemporal dynamics of mRNA translation in physiologically relevant contexts, paving the way for future explorations into compartment-specific translation control.

From a translational research perspective, there are tantalizing prospects for exploiting the LNPK–lysosome axis to regulate secretory protein synthesis in pathological conditions. Aberrant secretome profiles underlie numerous diseases, including cancer, neurodegeneration, and immune disorders. Modulating ER–lysosome interfaces or LNPK function could emerge as a novel therapeutic strategy to fine-tune secretory pathways and restore cellular homeostasis.

Beyond secretome mRNA translation, the findings invite broader reevaluation of intracellular compartmentalization in gene expression regulation. It becomes apparent that cellular architecture is not merely a backdrop but an active determinant guiding where and when key biosynthetic processes occur. Such spatial dimension adds complexity but also opportunity for targeted cellular control mechanisms that have yet to be fully appreciated.

Intriguingly, this study sets the stage for dissecting how ribosome distribution and polysome dynamics integrate with membrane contact sites to sculpt protein synthesis landscapes. LNPK’s role as a nexus at ER junctions hints at a multiprotein complex that may coordinate membrane remodeling, ribosome recruitment, and mRNA localization—a hypothesis ripe for future molecular characterization.

As the field moves forward, it will be essential to elucidate the precise molecular underpinnings by which lysosomes facilitate enhanced ribosome loading on secretome mRNAs. Potential mechanisms might involve localized signaling cascades, lipid microdomain compositions, or protein-protein interactions that stabilize translating ribosomes at these ER subdomains. Understanding these will deepen our grasp on translational regulation in subcellular contexts.

In sum, this pioneering work uncovers a novel paradigm wherein the ER and lysosome collaborate via LNPK-marked junctions to spatially orchestrate secretome mRNA translation. By illuminating this sophisticated level of cellular organization, the study not only pushes the frontiers of cell biology but also opens exciting vistas for biomedical innovation targeting the secretory machinery.

Subject of Research:
The spatial regulation of secretome mRNA translation by lysosomes and lunapark-marked endoplasmic reticulum junctions.

Article Title:
Secretome translation shaped by lysosomes and lunapark-marked ER junctions

Article References:
Choi, H., Liao, YC., Yoon, Y.J. et al. Secretome translation shaped by lysosomes and lunapark-marked ER junctions. Nature (2025). https://doi.org/10.1038/s41586-025-09718-0

Image Credits:
AI Generated

DOI:
https://doi.org/10.1038/s41586-025-09718-0